跳至主要内容
临床试验/EUCTR2021-000989-15-FR
EUCTR2021-000989-15-FR招募中1 期

Oxytocin versus Prostaglandins for labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening: a multicenter non inferiority randomized trial - OPIC

niversity Hospital, Tours0 个研究点目标入组 1,494 人开始时间: 2021年3月1日最近更新:
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
1,494

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Pregnant woman
  • = 18 years old
  • With a singleton cephalic pregnancy
  • Between =37+0 weeks and = 42+0 weeks of gestation
  • Gestational age estimated from the first trimester ultrasound (realized between 11+0 and 13+6 weeks of gestation)
  • With a medical indication of labor with a previous pharmacological or mechanical cervical ripening of 24 hours
  • Bishop score = 6 at inclusion (unfavorable cervix)
  • French health insurance policy holder
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1494
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Any measures of legal protection
  • Prior caesarean section or uterine scar
  • Contra-indications to a vaginal delivery
  • Foetus with suspected severe congenital abnormalities
  • Pathological foetal heart rate
  • Contra-indications to ANGUSTA® (oral misoprostol, cervical ripening agent)
  • Contra-indications to PROPESS® (vaginal slow releasing system of dinoprostone, cervical ripening agent)
  • Contra-indications to PROSTINE® (vaginal gel of dinoprostone, cervical ripening agent)
  • Contra-indications for using oxytocin
  • Woman in labor or with more than 3 contractions / 10 minutes

研究者

发起方
niversity Hospital, Tours

相似试验